Covington Investment Advisors Inc. Bristol Myers Squibb CO Transaction History

Covington Investment Advisors Inc.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 13, 2019	SELL	$42.77 - $50.71 $1.77 Million - $2.1 Million	-41,440 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$44.62 - $49.34 $12,270 - $13,568	275 Added 0.67%	41,440 $1.88 Million
Q1 2019 May 13, 2019	BUY	$45.12 - $53.8 $55,046 - $65,636	1,220 Added 3.05%	41,165 $1.96 Million
Q4 2018 Feb 13, 2019	SELL	$48.76 - $63.23 $3,364 - $4,362	-69 Reduced 0.17%	39,945 $2.08 Million
Q3 2018 Nov 14, 2018	BUY	$55.19 - $62.25 $16,557 - $18,675	300 Added 0.76%	40,014 $2.48 Million
Q1 2018 May 10, 2018	BUY	$59.92 - $68.98 $87,183 - $100,365	1,455 Added 3.8%	39,714 $2.51 Million
Q4 2017 Feb 13, 2018	BUY	$59.94 - $65.35 $56,943 - $62,082	950 Added 2.55%	38,259 $2.35 Million
Q3 2017 Nov 02, 2017	SELL	$55.23 - $63.74 $19,606 - $22,627	-355 Reduced 0.94%	37,309 $2.38 Million
Q2 2017 Nov 02, 2017	SELL	N/A	-100 Reduced 0.26%	37,664 $2.1 Million
Q1 2017 Nov 02, 2017	BUY	N/A	37,764	37,764 $2.05 Million

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Covington Investment Advisors Inc., based on Form 13F filings with the SEC.

Stay updated on Covington Investment Advisors Inc. with notifications on news.